Researchers at the University of Michigan (U-M) and the Icahn School of Medicine at Mount Sinai have found that a nasal vaccine adjuvant, or a substance added to nasal vaccines to trigger a stronger immune response, can stop COVID-19 infection in both young and old mice.
